Alcon Operating Income 2019-2022 | ALC

Alcon annual/quarterly operating income history and growth rate from 2019 to 2022. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Alcon operating income for the quarter ending September 30, 2022 was $0.205B, a 925% increase year-over-year.
  • Alcon operating income for the twelve months ending September 30, 2022 was $833M, a 54.55% increase year-over-year.
  • Alcon annual operating income for 2021 was $0.58B, a 220.33% decline from 2020.
  • Alcon annual operating income for 2020 was $-0.482B, a 157.75% increase from 2019.
  • Alcon annual operating income for 2019 was $-0.187B, a 24.6% decline from 2018.
Alcon Annual Operating Income
(Millions of US $)
2021 $580
2020 $-482
2019 $-187
2018 $-248
Alcon Quarterly Operating Income
(Millions of US $)
2022-09-30 $205
2022-06-30 $200
2022-03-31 $246
2021-12-31 $182
2021-09-30 $20
2021-06-30 $229
2021-03-31 $149
2020-12-31 $141
2020-09-30 $-129
2020-06-30 $-466
2020-03-31 $-28
2019-12-31 $-68
2019-09-30 $-18
2019-06-30 $-53
2019-03-31 $-48
2018-12-31
2018-09-30 $-284
2018-06-30 $38
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $37.369B $8.291B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $230.517B 25.29
Edwards Lifesciences (EW) United States $50.772B 33.11
STERIS (STE) Ireland $21.864B 27.21
Teleflex (TFX) United States $12.124B 19.67
Fresenius Medical Care AG KGaA (FMS) Germany $11.123B 11.16
Penumbra (PEN) United States $9.913B 2372.91
Globus Medical (GMED) United States $7.951B 40.42
Glaukos (GKOS) United States $2.458B 0.00
Integer Holdings (ITGR) United States $2.435B 19.55
AVANOS MEDICAL, INC (AVNS) United States $1.469B 20.92
Nevro (NVRO) United States $1.410B 0.00
Paragon 28 (FNA) United States $1.346B 0.00
Artivion (AORT) United States $0.566B 0.00